AMBUJACEM - Swing Trade Analysis with AI Signals
Back to Listπ Swing Trade Rating: 3.1
| Stock Code | AMBUJACEM | Market Cap | 1,05,369 Cr. | Current Price | 424 βΉ | High / Low | 625 βΉ |
| Stock P/E | 27.0 | Book Value | 213 βΉ | Dividend Yield | 0.47 % | ROCE | 3.29 % |
| ROE | 7.70 % | Face Value | 2.00 βΉ | DMA 50 | 438 βΉ | DMA 200 | 492 βΉ |
| Chg in FII Hold | 0.03 % | Chg in DII Hold | -0.02 % | PAT Qtr | 1,742 Cr. | PAT Prev Qtr | -59.2 Cr. |
| RSI | 46.2 | MACD | -4.31 | Volume | 22,64,633 | Avg Vol 1Wk | 29,03,250 |
| Low price | 394 βΉ | High price | 625 βΉ | PEG Ratio | 1.98 | Debt to equity | 0.02 |
| 52w Index | 13.0 % | Qtr Profit Var | 214 % | EPS | 14.4 βΉ | Industry PE | 29.9 |
AMBUJACEM shows mixed fundamentals for swing trading. The stock trades at a fair P/E of 27.0 compared to the industry average of 29.9, suggesting reasonable valuation. EPS is modest at 14.4 βΉ, and dividend yield is 0.47%. ROCE (3.29%) and ROE (7.70%) are weak, reflecting limited efficiency. On the positive side, quarterly profit surged to 1,742 Cr. from a loss of -59.2 Cr., showing strong recovery. Technically, RSI at 46.2 is neutral, while MACD is negative (-4.31), indicating weak momentum. The stock trades below DMA 50 (438 βΉ) and DMA 200 (492 βΉ), suggesting bearish undertones.
π‘ Optimal Entry Price: Around 410β420 βΉ, closer to support levels near 394 βΉ.
π Exit Strategy: If already holding, consider exiting near 460β480 βΉ or on weakness if RSI drops below 45.
β Positive
- π Fair P/E ratio (27.0) compared to industry average (29.9).
- π Strong quarterly profit recovery (1,742 Cr. vs -59.2 Cr.).
- π° Low debt to equity ratio (0.02).
- π Slight increase in FII holding (+0.03%).
β οΈ Limitation
- π Weak ROCE (3.29%) and ROE (7.70%).
- π Neutral RSI (46.2) and negative MACD (-4.31) show weak momentum.
- π Decline in DII holding (-0.02%).
- π EPS of 14.4 βΉ is modest relative to price.
π° Company Negative News
- β οΈ Weak efficiency metrics despite profit recovery.
- π Stock trading below DMA 50 and DMA 200, showing bearish trend.
π Company Positive News
- π Quarterly profit turnaround from loss to strong gain.
- π Valuation remains fair compared to industry peers.
- π° Dividend payout continues, supporting investor confidence.
π Industry
- π Industry P/E at 29.9, slightly higher than companyβs 27.0, showing AMBUJACEM trades at a discount.
- π Cement industry outlook remains stable with long-term demand drivers.
π Conclusion
AMBUJACEM is a moderately suitable candidate for swing trading, supported by fair valuation and strong profit recovery. Entry is safer around 410β420 βΉ near support. If already holding, exit near 460β480 βΉ to secure gains. Short-term traders should remain cautious as weak efficiency metrics and negative momentum indicators limit upside potential.